Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Working Capital/Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   Working Capital/Sales(x) 1.573.273.576.677.14

What is the latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 1.57 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20241.57
Mar20233.27
Mar20223.57
Mar20176.67
Mar20167.14

How is Working Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2024 1.57
-51.99
Mar2023 3.27
-8.40
Mar2022 3.57
-46.48
Mar2017 6.67
-6.58
Mar2016 7.14 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Working Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹2,120.6 Cr 1.3% 9.9% 103.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹435,407.0 Cr 0.3% 0.2% 46% Stock Analytics
DIVIS LABORATORIES ₹157,489.0 Cr -2.7% -0.1% 58.9% Stock Analytics
CIPLA ₹117,443.0 Cr -3% -8.6% 19% Stock Analytics
DR REDDYS LABORATORIES ₹103,338.0 Cr -0.1% -3.4% 7.2% Stock Analytics
ZYDUS LIFESCIENCES ₹99,244.9 Cr 0.8% 1.8% 48.1% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1.3%

9.9%

103.9%

SENSEX

0.7%

2.5%

17%


You may also like the below Video Courses